Background: The angiogenesis process is regulated by many factors, such as Hypoxia-Inducible Factor-1 (HIF-1) and Vascular Endothelial Growth Factor (VEGF). Metformin has demonstrated its ability to inhibit cell growth and the LY294002 is the major inhibitor of PI3K/AKT/mTOR pathway that has antiangiogenic properties.
Methods: Canine mammary tumor cell lines CMT-U229 and CF41 were treated with metformin and LY294002. Cell viability, protein and gene expression of VEGF and HIF-1 were determined in vitro. For the in vivo study, CF41 cells were inoculated in female athymic nude mice treated with either metformin or LY294002. The microvessel density by immunohistochemistry for CD31 as well as the gene and protein expression of HIF-1 and VEGF were evaluated.
Results: The treatment with metformin and LY294002 was able to reduce the cellular viability after 24 hours. The protein and gene expression of HIF-1 and VEGF decreased after treatment with metformin and LY294002. In the in vivo study, there was a decrease in tumor size, protein and gene expression of HIF-1 and VEGFA, in addition to the decreasing of CD31 expression after all treatments.
Conclusion: Our results demonstrate the effectiveness of metformin and LY294002 in controlling the angiogenesis process in mammary tumors by VEGF and HIF-1, the most important angiogenic markers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2174/1871520619666181218164050 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metformin activates the PI3K/AKT/BDNF axis to attenuate postoperative cognitive dysfunction.
Neuropharmacology
March 2025
Department of Anesthesiology and Pain Medicine, The Affiliated Hospital of Jiaxing University, Jiaxing, 314000, Zhejiang, China. Electronic address:
Article Synopsis
- Postoperative cognitive dysfunction (POCD) is a common issue after surgery and anesthesia, and this study investigates how the antidiabetic drug metformin may help improve cognitive function in such cases.
- The researchers created a mouse model of POCD and discovered that metformin improved cognitive abilities and reduced anxiety, while also enhancing synaptic health in the brain's hippocampus.
- Metformin works by reducing neuroinflammation and activating the PI3K/AKT signaling pathway, which increases brain-derived neurotrophic factor (BDNF), suggesting it might be a new treatment approach for preventing POCD.
The role of PI3K/AKT-related proteins in di(2-ethyl)hexylphthalate-induced BG-1 and MCF-7 cell proliferation, and inhibition by metformin.
Immunopharmacol Immunotoxicol
June 2023
Department of Environmental Hygiene, Public Health Collage, Harbin Medical University, Harbin, China.
Objective: To investigate the molecular mechanism of the proliferation and migration of BG-1 and MCF-7cells induced by DEHP, and the antagonistic effect of metformin.
Methods: The proliferation, cell cycle progression, migration, and invasion abilities of BG-1 and MCF-7 cancer cells were examined Cell Counting Kit-8, flow cytometry, Transwell, and scratch assays. E2F1, SKP2, cyclin D1, vimentin, E-cadherin, and GSK-3β, all of which play key roles in cancer development the PI3K/AKT signaling pathway, were examined by immunofluorescence and immunocytochemistry.
Metformin Facilitates Osteoblastic Differentiation and M2 Macrophage Polarization by PI3K/AKT/mTOR Pathway in Human Umbilical Cord Mesenchymal Stem Cells.
Stem Cells Int
June 2022
Department of Hematology, Huashan Hospital, Fudan University, Shanghai 200040, China.
Mesenchymal stem cells (MSCs) are the most promising multipotent stem cells that can differentiate into osteoblasts, chondrocytes, and adipocytes. This cellular flexibility contributes to widespread clinical use of MSCs in tissue repair and regeneration. The immune system is a key player in regulating bone remodeling.
View Article and Find Full Text PDFMetformin Promotes Differentiation and Attenuates HO-Induced Oxidative Damage of Osteoblasts the PI3K/AKT/Nrf2/HO-1 Pathway.
Front Pharmacol
March 2022
Department of Orthopedics, First Hospital of China Medical University, Shenyang, China.
At present, the drug treatment of osteoporosis is mostly focused on inhibiting osteoclastogenesis, which has relatively poor effects. Metformin is a drug that can potentially promote osteogenic differentiation and improve bone mass in postmenopausal women. We aimed to detect the molecular mechanism underlying the osteogenic effect of metformin.
View Article and Find Full Text PDFMetformin prevents methylglyoxal-induced apoptosis by suppressing oxidative stress in vitro and in vivo.
Cell Death Dis
January 2022
Collaborative Innovation Center for Prevention and Treatment of Cardiovascular Disease of Sichuan Province, Drug Discovery Research Center, Southwest Medical University, Luzhou, China.
Methylglyoxal (MGO) is an active metabolite of glucose and plays a prominent role in the pathogenesis of diabetic vascular complications, including endothelial cell apoptosis induced by oxidative stress. Metformin (MET), a widely prescribed antidiabetic agent, appears to reduce excessive reactive oxygen species (ROS) generation and limit cell apoptosis. However, the molecular mechanisms underlying this process are still not fully elucidated.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!